Top Markets
Coin of the day
Diffusion Pharmaceuticals Inc. Diffusion Pharmaceuticals Inc.

Diffusion Pharmaceuticals Inc.

DFFN
Rangering i aksjer #31359
As a biopharmaceutical enterprise, Diffusion Pharmaceuticals Inc. concentrates... As a biopharmaceutical enterprise, Diffusion Pharmaceuticals Inc. concentrates on pioneering new treatments that bolster the body's efficiency in oxygen distribution. The company's flagship investigational therapy is Trans Sodium Crocetinate, which is formulated to facilitate the spread of oxygen into tissues. This compound is additionally under development for its application in addressing COVID-19. Headquartered in Charlottesville, Virginia, Diffusion Pharmaceuticals Inc. was established in 2001.
Aksjekurs
$6.60
Sist synkronisert: 2023-08-16
Markedsverdi
$13.46M
Endring (1 dag)
11.68%
Endring (1 år)
0.00%
Land
US
Handel Diffusion Pharmaceuticals Inc. (DFFN)

Kategori

P/B-forhold for Diffusion Pharmaceuticals Inc. (DFFN)
P/B-forhold per 2026 TTM: 0
Ifølge Diffusion Pharmaceuticals Inc. sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/B-forhold (TTM) 0. Ved slutten av 2026 hadde selskapet et P/B-forhold på 0.
P/B-historikk for Diffusion Pharmaceuticals Inc. fra 2026 til 2026
P/B-forhold ved hvert års slutt
År P/B-forhold Endre
Ikke nok data for de angitte datoene.
P/B-forhold for lignende selskaper eller konkurrenter
Selskap P/B-forhold Forskjell i P/B-forhold Land
6.3419 -
US
6.2413 -
NL
2.5054 -
AU
- -
CH
3.4612 -
BE